Skip to main content
logo
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
303.06
+2.18 (0.72%)
At close: Nov 9, 2026, 4:00 PM EST
306.56
+3.50 (1.15%)
Pre-market: Nov 10, 2026, 7:34 AM EST

Krystal Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
225.17204.8389.1610.93-139.98-69.57
Depreciation & Amortization
2.342.453.214.813.392.77
Loss (Gain) From Sale of Assets
----100--
Loss (Gain) From Sale of Investments
-4.89-6.45-7.78-7.280.1-
Stock-Based Compensation
55.4754.5149.1339.9333.2315.32
Other Operating Activities
6.34-18.064.151.320.031.04
Change in Accounts Receivable
-4-22.12-62.71-42.04--
Change in Inventory
-4.26-6.29-11.91-4.48--
Change in Accounts Payable
4.110.831.01-0.1-1.250.71
Change in Income Taxes
3.18-12.39-1.62---
Change in Other Net Operating Assets
40.463.5560.768.093.911.79
Operating Cash Flow
323.93200.87123.42-88.8-100.57-47.94
Operating Cash Flow Growth
83.84%62.75%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13.85-11.95-4.24-11.8-52.98-68.34
Sale of Property, Plant & Equipment
-0.44-100--
Investment in Securities
-258.14-46.9-159.2-5.56-61.1-158.43
Investing Cash Flow
-271.99-58.42-163.4482.64-114.08-226.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
40.7822.6632.4203.536355.65
Repurchase of Common Stock
-17.1-13.96-5.39-0.75-0.65-
Other Financing Activities
------7.96
Financing Cash Flow
23.678.7127.01202.7535.35347.69

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-5.380.29-0.46-0.16-0.04-
Net Cash Flow
70.24151.44-13.46196.43-179.3572.98

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
310.08188.91119.18-100.6-153.55-116.27
Free Cash Flow Growth
87.26%58.51%----
Free Cash Flow Margin
65.97%48.55%41.02%-198.43%--
Free Cash Flow Per Share
10.146.314.01-3.63-6.02-5.24
Levered Free Cash Flow
221.5993.9392.99-74.54-90.02-85.35
Unlevered Free Cash Flow
221.5993.9392.99-74.54-90.02-84.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
24.5215.675.67---
Change in Working Capital
39.5-36.42-14.46-38.522.662.51
SEC Filings: 10-K · 10-Q